296 related articles for article (PubMed ID: 19526383)
1. Pathophysiology of the no-reflow phenomenon.
Vrints CJ
Acute Card Care; 2009; 11(2):69-76. PubMed ID: 19526383
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
3. Myocardial no-reflow in humans.
Niccoli G; Burzotta F; Galiuto L; Crea F
J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Monassier JP
Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
[TBL] [Abstract][Full Text] [Related]
5. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Alfayoumi F; Srinivasan V; Geller M; Gradman A
Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
[TBL] [Abstract][Full Text] [Related]
6. Microvascular dysfunction following primary percutaneous coronary intervention in the setting of ST-elevation myocardial infarction.
Ramaraj R; Movahed MR
J Invasive Cardiol; 2008 Nov; 20(11):603-14. PubMed ID: 18987402
[TBL] [Abstract][Full Text] [Related]
7. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
[TBL] [Abstract][Full Text] [Related]
8. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
9. [The no-reflow phenomenon following percutaneous coronary intervention].
Schwartzenberg S; Halkin A; Finkelstein A; Keren G; Banai S
Harefuah; 2009 Jun; 148(6):381-5, 411. PubMed ID: 19902604
[TBL] [Abstract][Full Text] [Related]
10. No-reflow phenomenon and prognosis in patients with acute myocardial infarction.
Ito H
Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):499-506. PubMed ID: 16932767
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
12. The no-reflow phenomenon: State of the art.
Bouleti C; Mewton N; Germain S
Arch Cardiovasc Dis; 2015 Dec; 108(12):661-74. PubMed ID: 26616729
[TBL] [Abstract][Full Text] [Related]
13. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Lerman A; Holmes DR; Herrmann J; Gersh BJ
Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
[TBL] [Abstract][Full Text] [Related]
14. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
Rezkalla SH; Kloner RA
Catheter Cardiovasc Interv; 2008 Dec; 72(7):950-7. PubMed ID: 19021281
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
[TBL] [Abstract][Full Text] [Related]
16. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
17. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
18. Role of adenosine as adjunctive therapy in acute myocardial infarction.
Forman MB; Stone GW; Jackson EK
Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725
[TBL] [Abstract][Full Text] [Related]
19. Microvascular obstruction: underlying pathophysiology and clinical diagnosis.
Bekkers SC; Yazdani SK; Virmani R; Waltenberger J
J Am Coll Cardiol; 2010 Apr; 55(16):1649-60. PubMed ID: 20394867
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.
Srinivasan M; Rihal C; Holmes DR; Prasad A
Circulation; 2009 Mar; 119(9):1311-9. PubMed ID: 19273732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
